Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol (Q45034136)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol
scientific article

    Statements

    Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit